Experimental combo shows promise in tough lung cancer
Disease control
Completed
This early-phase study tested whether adding an experimental drug called plinabulin to the standard immunotherapy nivolumab is safe and effective for people with advanced non-small cell lung cancer that has spread. The study enrolled 18 adults whose cancer had worsened after prio…
Phase: PHASE1 • Sponsor: Lyudmila Bazhenova, M.D. • Aim: Disease control
Last updated May 01, 2026 21:57 UTC